Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Steve, Huvelle"'
Autor:
Steve Huvelle, Antoine Pinon, Christine Coulon, Thomas Bonasera, Catherine Chapon, Thibaut Naninck, Roger Le Grand, Chris M. Parry, Bertrand Kuhnast, Fabien Caillé
Publikováno v:
ACS Omega, Vol 9, Iss 40, Pp 41732-41741 (2024)
Externí odkaz:
https://doaj.org/article/19496fc1ee754918bc9b9e3a2670b273
Autor:
Sara Cherradi, Véronique Garambois, Johanna Marines, Augusto Faria Andrade, Alexandra Fauvre, Olivia Morand, Manon Fargal, Ferial Mancouri, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, Marta Jarlier, Gerald Loussaint, Steve Huvelle, Nicolas Joubert, Thibault Mazard, Céline Gongora, Philippe Pourquier, Florence Boissière-Michot, Maguy Del Rio
Publikováno v:
Cell & Bioscience, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Background Tumor resistance is a frequent cause of therapy failure and remains a major challenge for the long-term management of colorectal cancer (CRC). The aim of this study was to determine the implication of the tight junctional protein
Externí odkaz:
https://doaj.org/article/612613fc1c27490d8675f675e72b711a
Autor:
Ofelia Feuillâtre, Camille Gély, Steve Huvelle, Christine B. Baltus, Ludovic Juen, Nicolas Joubert, Audrey Desgranges, Marie-Claude Viaud-Massuard, Camille Martin
Publikováno v:
ACS Omega, Vol 5, Iss 3, Pp 1557-1565 (2020)
Externí odkaz:
https://doaj.org/article/ee9481fb6507457dbd19485a634fd2f0
Autor:
William Parisot, Steve Huvelle, Mansour Haddad, Guillaume Lefèvre, Phannarath Phansavath, Virginie Ratovelomanana-Vidal
Publikováno v:
Organic Chemistry Frontiers. 10:1309-1315
Efficient access to 5H-chromeno[3,4-c]pyridines using Ru-catalyzed [2 + 2 + 2] cycloaddition of α,ω-diynes with cyanamides was developed, providing valuable tricyclic pyridine building blocks and enabling access to a biologically relevant intermedi
Autor:
Steve Huvelle, Pascal Matton, Christine Tran, Marie-Noelle Rager, Mansour Haddad, Virginie Ratovelomanana-Vidal
Publikováno v:
Organic Letters. 24:5126-5131
Autor:
Steve, Huvelle, Pascal, Matton, Christine, Tran, Marie-Noelle, Rager, Mansour, Haddad, Virginie, Ratovelomanana-Vidal
Publikováno v:
Organic letters. 24(28)
A convenient method for the ruthenium-catalyzed synthesis of benzo[
Autor:
Ludovic Juen, Camille Gély, Audrey Desgranges, Ofelia Feuillâtre, Nicolas Joubert, Camille Martin, Christine B. Baltus, Marie-Claude Viaud-Massuard, Steve Huvelle
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 3, Pp 1557-1565 (2020)
ACS Omega, Vol 5, Iss 3, Pp 1557-1565 (2020)
Antibody–drug conjugates (ADCs) are the spearhead of targeted therapies. According to the technology used, the conjugation of a cytotoxic drug to an antibody can produce suboptimal heterogeneous species, impacting the overall efficacy. Herein, we d
Publikováno v:
Organicbiomolecular chemistry. 20(1)
A self-immolative spacer based on disymetrical N,N’ bis carbamate aniline is introduced to liberate a substrate from a precursor after dual activation. The proof of principle of its exclusive selectivity for substrate liberation has been conducted
Autor:
Steve Huvelle, Pascal Matton, Phannarath Phansavath, Virginie Ratovelomanana-Vidal, Mansour Haddad
Publikováno v:
SYNTHESIS
SYNTHESIS, Georg Thieme Verlag, In press, ⟨10.1055/s-0040-1719831⟩
SYNTHESIS, Georg Thieme Verlag, In press, ⟨10.1055/s-0040-1719831⟩
Metal-catalyzed [2+2+2] cycloaddition is a powerful tool that allows rapid construction of functionalized 6-membered carbo- and heterocycles in a single step through an atom-economical process with high functional group tolerance. The reaction is usu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348535072483e5ad821d258759a8446a
https://hal.archives-ouvertes.fr/hal-03364338
https://hal.archives-ouvertes.fr/hal-03364338
Autor:
Imene Ait Mohamed Amar, Steve Huvelle, Emmanuel Douez, Stéphanie Letast, Sylvain Henrion, Marie-Claude Viaud-Massuard, Nicolas Aubrey, Emilie Allard-Vannier, Nicolas Joubert, Caroline Denevault-Sabourin
Publikováno v:
European Journal of Medicinal Chemistry. 229:114063
Antibody-drug conjugates (ADCs) are targeted therapies, mainly used in oncology, consisting in a three-component molecular architecture combining a highly potent drug conjugated via a linker onto a monoclonal antibody (mAb), designed for the selectiv